Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NL-OMON25436
NL-OMON25436CompletedNot Applicable

Randomized Trial of optimal conventional therapy versus optimal conventional therapy plus counterpressure manoeuvres in patients with neurally-mediated syncope.

Academisch Medisch Centrum0 sites200 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
200
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

  1. J Am Coll Cardiol. 2006 Oct 17;48(8):1652-7. Epub 2006 Sep 26.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •1. Clinical diagnosis of classical neurally-mediated reflex syncope, based on the medical history ór non-classical diagnosis of neurally-mediated reflex syncope and a positive tilt-table test.

Exclusion Criteria

  • •1. Suspected or certain heart disease and high likelihood of cardiac syncope:
  • •a. Syncope preceded by palpitations or precordial pain;

Investigators

Similar Trials

Not yet recruiting
Not Applicable
Randomized Clinical Trial for Optimal Cardiac Rehabilitation.
NL-OMON19956Radboud University Nijmegen Medical Centre210
Completed
Not Applicable
Randomized Clinical Trial for optimal Cardiac Rehabilitation: A traditional Dutch Cardiac Rehabilitation Program versus a Canadian High Efficiency Cardiac Rehabilitation Programcoronary syndromeheart attack10028593
NL-OMON36989niversitair Medisch Centrum Sint Radboud210
Recruiting
Phase 1
Hypomemylating Agents Combination With eDC Therapy for Elderly Patients With Myelodysplastic SyndromeMyelodysplastic SyndromesDendritic CellHypomethylating AgentsImmunotherapy
NCT04999943Affiliated Hospital to Academy of Military Medical Sciences40
Suspended
Not Applicable
A Randomized Clinical Trial of the Effectiveness of Ventilation by Oxylator EMX versus Bag-Valve Device in pre-hospital emergency patients.All emergency conditions that require mask ventilation.
NL-OMON23375CPR Medical, Toronto Canada, www.cprmedic.com200
Completed
Phase 2
Treatment of cardiac amyloid light-chain amyloidosis with the green tea compound epigallocatechin-3-galiateAmyloid light-chain amyloidosisNutritional, Metabolic, EndocrineAmyloidosis
ISRCTN68399350Ruprecht-Karls-University of Heidelberg (Germany)38